CEFOTETAN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Cefotetan, and what generic alternatives are available?
Cefotetan is a drug marketed by Fresenius Kabi Usa, Hikma, West-ward Pharm Corp, and B Braun. and is included in five NDAs.
The generic ingredient in CEFOTETAN is cefotetan disodium. There are three drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the cefotetan disodium profile page.
Summary for CEFOTETAN
US Patents: | 0 |
Applicants: | 4 |
NDAs: | 5 |
Finished Product Suppliers / Packagers: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 59 |
Clinical Trials: | 6 |
Patent Applications: | 4,929 |
Drug Prices: | Drug price information for CEFOTETAN |
DailyMed Link: | CEFOTETAN at DailyMed |
Recent Clinical Trials for CEFOTETAN
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Fundação de Amparo à Pesquisa do Estado de São Paulo | Phase 4 |
Federal University of São Paulo | Phase 4 |
Chonbuk National University Hospital | Phase 1 |
Pharmacology for CEFOTETAN
Drug Class | Cephalosporin Antibacterial |
Anatomical Therapeutic Chemical (ATC) Classes for CEFOTETAN
US Patents and Regulatory Information for CEFOTETAN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Fresenius Kabi Usa | CEFOTETAN | cefotetan disodium | INJECTABLE;INJECTION | 065374-001 | Aug 9, 2007 | AP | RX | No | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
B Braun | CEFOTETAN AND DEXTROSE IN DUPLEX CONTAINER | cefotetan disodium | INJECTABLE;INJECTION | 065430-001 | Aug 9, 2007 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Hikma | CEFOTETAN | cefotetan disodium | INJECTABLE;INJECTION | 091031-001 | Oct 26, 2011 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |